An observational study in Obstructive Sleep Apnea, sponsored by National University Hospital, Singapore. Not yet recruiting at 1 site in Singapore. Open to participants aged 22 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-06-20.
Sponsored by National University Hospital, Singapore · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 18 studies in Sleep Apnea, Obstructive with a site in Singapore — 4 open to participants now, 4 under way, none of them phase 3. Sleep Apnea, Obstructive · Singapore.
Among the 18 studies in Sleep Apnea, Obstructive with a site in Singapore, this one is one of 3 that started in 2024, is one of 7 observational ones, and was the 15th registered.
2,246 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.
Browse Sleep Apnea, Obstructive studies →4 of the 18 studies in Sleep Apnea, Obstructive with a site in Singapore are open now. Recruiting first, the newest first:
National University Hospital, Singapore · Sites in Singapore
Ages 45+
National University of Singapore · Sites in Singapore
Ages 22–99
National University Hospital, Singapore · Sites in Singapore
Ages 40–99
A study can be open while its sites in Singapore have not opened yet or have stopped. Only those recruiting at a site in Singapore →
Of the 317 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 124 (39%) stop at 75 or younger; 53 take children under 18; 66 take healthy volunteers.
This study: 22 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
18 studies; the count open now beside each. This study's row is marked.
First in 2011; this study’s year is marked. 3 started in 2024.
This study's planned enrollment of 150 is above the median of 105 across 668 observational studies indexed under Sleep Apnea, Obstructive.
Median enrollment 44 across the 11 interventional studies, 204 across the 7 observational. Of the 12 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 18 have an industry lead sponsor. The 8 most frequent:
National University Hospital, Singapore is the lead sponsor of 455 studies on the registry; 100 are open to participants now.
National University Hospital, Singapore has 3 studies filed under Sleep Apnea, Obstructive — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 18 studies in Sleep Apnea, Obstructive with a site in Singapore, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
To compare the blood pressure control and cognitive responses of three groups of patients: those diagnosed with Obstructive Sleep Apnea (OSA) and treated with Continuous Positive Airway Pressure (CPAP) for at least six months, those diagnosed with OSA but not treated, and those without OSA.
This study is designed as an observational, cross-sectional investigation at the National University Hospital and Alexandra Hospital. The research aims to enroll 50 eligible patients in each of the three groups (OSA treated, OSA untreated, and non-OSA, totaling 150 participants). The recruited participants will undergo ambulatory blood pressure monitoring (ABPM) and the Montreal Cognitive Assessment (MoCA). ABPM is a widely used, noninvasive method to determine patients' blood pressure control. MoCA is a widely used screening tool designed to assess cognitive function and detect mild cognitive impairment or early signs of dementia. The MoCA evaluates various cognitive domains, including attention, memory, language, visuospatial abilities, executive functions, and orientation. It consists of a series of tasks and questions that assess different aspects of cognitive functioning, such as drawing specific shapes, recalling words or numbers, and performing simple calculations. A trained healthcare professional will administer the digital version of the MoCA, which usually takes less than 30 minutes to complete. The MoCA has been validated for use in diverse populations and has shown good sensitivity in detecting mild cognitive impairment. The maximum score on the MoCA is 30. Lower scores may indicate potential cognitive impairment.
Individuals who fulfil the inclusion criteria but not the exclusion criteria will be recruited.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients with OSA treated with CPAP for at least six months
Diagnostic Test: Ambulatory blood pressure monitoring and Montreal Cognitive Assessment
Patients with OSA not treated with CPAP
Diagnostic Test: Ambulatory blood pressure monitoring and Montreal Cognitive Assessment
Patients underwent a sleep study and were diagnosed not to have OSA
Diagnostic Test: Ambulatory blood pressure monitoring and Montreal Cognitive Assessment
Noninvasive tests to assess blood pressure control and cognition
24-hour mean systolic blood pressure
A 24-hour ambulatory blood pressure monitoring will be performed
Time frame: Within 4 weeks after consent (one time)
Montreal Cognitive Assessment (MoCA)
Montreal Cognitive Assessment scale (0-30). Lower the scale means more severe cognitive impairment
Time frame: Within 4 weeks after consent (one time)
Office systolic blood pressure
Office blood pressure will be record
Time frame: Within 4 weeks after consent (one time)
Epworth Sleepiness Scale
Epworth Sleepiness Scale (4-24). Higher scale means more severe daytime sleepiness
Time frame: Within 4 weeks after consent (one time)
Nocturnal blood pressure dipping
Percentage of Participants with \>10% drop in nocturnal systolic blood pressure based on the ambulatory BP monitoring
Time frame: Within 4 weeks after consent (one time)
24-hour systolic blood pressure <130 mmHg
24-hour systolic blood pressure \<130 mmHg based on the ambulatory BP monitoring
Time frame: Within 4 weeks after consent (one time)
24-hour systolic blood pressure <120 mmHg
24-hour systolic blood pressure \<120 mmHg based on the ambulatory BP monitoring
Time frame: Within 4 weeks after consent (one time)
Montreal Cognitive Assessment (MoCA) <27
Prevalence of participants with Montreal Cognitive Assessment (MoCA) \<27
Time frame: Within 4 weeks after consent (one time)
Montreal Cognitive Assessment (MoCA) <20
Prevalence of participants with Montreal Cognitive Assessment (MoCA) \<20
Time frame: Within 4 weeks after consent (one time)
MoCA score <27 (for those with >10 years of education) and <26 (for those with ≤10 years of education)
Prevalence of participants with MoCA score \<27 (for those with \>10 years of education) and \<26 (for those with ≤10 years of education)
Time frame: Within 4 weeks after consent (one time)
Plan to share: Yes — Plan to make individual participant data (IPD) available to other researchers at least 5 years after study completion, subjected to final approval by the PI
Supporting information: Clinical study report
Time frame: At least 5 years after study completion
Access criteria: Plan to make individual participant data (IPD) available to other researchers at least 5 years after study completion, subjected to final approval by the PI
No publications or documents are linked to this record.
Start is estimated for Jul 2024; primary completion for Jun 2025, 11 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National University Hospital, Singapore →